Synoptics Health, a new division of Synoptics, a leading developer of digital imaging systems for scientific applications, is delighted to announce the appointment of Peskett Solutions Ltd. as its exclusive UK and Ireland distribution partner for ProReveal, an ultra sensitive fluorescent test for detecting protein contamination on surgical instruments and a ProReveal viewer.
Matthew Peskett, Managing Director of Peskett Solutions explained: “We saw the ProReveal technology being developed by Synoptics Health in collaboration with
Queen Mary University of London and were amazed by how easily it could detect where protein contamination is located on a surgical instrument. Current protein tests don’t really tell you where the protein is on an instrument and in an SSD,
knowing where the protein is, can help you pin-point if and where, the issues lie with your decontamination process, and this is where ProReveal will provide a major benefit.”
Peskett added: “ We believethat ProReveal will be a real advance for decontamination testing and this is why we’re very excited to be chosen as UK distributors of this innovative technology.”
Paul Ellwood, CEO of Synoptics Health commented: “We are delighted to be partnering with such a well-respected decontamination company to help us support our ProReveal Test. Peskett Solutions has an extensive network of professionals with SSD expertise and this will make it quicker and easier for decontamination professionals to implement the ProReveal technology into their facility, confident that they will have expert guidance in their transition to a more sensitive and cost-effective protein decontamination testing method.”
